
|Articles|November 1, 1997
The American Journal of Managed Care
- November 1997
- Volume 3
- Issue 11
When Is a Cost-Effectiveness Claim Valid? How Much Should the FDA Care?
Advertisement
Articles in this issue
about 28 years ago
Healthcare Utilization Among Women with Eating Disordered Behaviorabout 28 years ago
Postpartum Depressionabout 28 years ago
Pharmaceutical Considerations of Common Herbal Medicineabout 28 years ago
Treatment Patterns for Heart Failure in a Primary Care Environmentabout 28 years ago
Enhancement of Compliance Among Patients with HypertensionNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Preoperative Weight Loss Is Feasible, Safe, and Cost-Effective for Colorectal Cancer
2
Single-Dose Oral Antibiotic Zoliflodacin Treats Drug-Resistant Gonorrhea
3
T-DXd Regimens Show Better Tolerability, Manageable Safety in High-Risk, HER2-Positive Early Breast Cancer
4
Evaluation of Albumin Platelet Product for Fibrosis Detection in MASLD
5













































